Ryzneuta

efbemalenograstim alfa · Evive Biotechnology Ireland Limited

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Ryzneuta, covering 2023-11-16 to 2026-08-19. Get the full timeline:

Most recent: EMA Authorised: Ryzneuta (efbemalenograstim alfa) — Fisiopharma S.r.l.